Clinical Evaluation Report (CER) writing is one of the most important regulatory requirements for medical device manufacturers seeking to market products in the European Union. Under the European Medical Device Regulation (EU MDR 2017/745), manufacturers must demonstrate that their devices are safe, perform as intended, and deliver clinical benefits supported by scientific evidence. A well-prepared CER writing medical device process is essential for obtaining and maintaining CE marking while ensuring ongoing regulatory compliance.

Preparing a Clinical Evaluation Report requires a structured approach, combining clinical data, literature reviews, risk assessments, post-market surveillance information, and regulatory expertise. Because the process is highly technical and continually evolving, many manufacturers choose experienced regulatory consultants to develop compliant CERs that meet the expectations of notified bodies and competent authorities.

What Is a Clinical Evaluation Report (CER)?

A Clinical Evaluation Report (CER) is a comprehensive scientific document that assesses the clinical safety and performance of a medical device. It evaluates available clinical evidence to demonstrate that the device complies with the General Safety and Performance Requirements (GSPRs) of the EU MDR.

The CER forms an integral part of the technical documentation required for CE marking and must be maintained throughout the product lifecycle.

Clinical evaluations are performed according to:

• EU MDR (EU 2017/745)
• MEDDEV 2.7/1 Rev. 4 guidance (where applicable)
• MDCG guidance documents
• ISO 14155 for clinical investigations
• ISO 14971 for risk management
• Relevant harmonized standards

Why CER Writing Is Important

Clinical evaluation is more than a regulatory obligation—it demonstrates that a device provides clinical benefits while minimizing risks to patients and users.

A professionally prepared CER helps manufacturers:

• Achieve CE marking
• Demonstrate device safety
• Prove clinical performance
• Meet notified body expectations
• Reduce regulatory delays
• Maintain market access
• Support post-market surveillance
• Improve regulatory confidence

Poor-quality CERs are among the most common reasons for notified body questions and delays during conformity assessment.

Key Components of a Clinical Evaluation Report

A compliant CER generally includes several essential sections.

Device Description

The report begins with a detailed description of the medical device, including:

• Intended purpose
• Intended users
• Patient population
• Device classification
• Design features
• Materials
• Mode of action
• Indications for use

This information establishes the foundation for the clinical evaluation.

Clinical Evaluation Plan (CEP)

The Clinical Evaluation Plan defines how the evaluation will be conducted.

It includes:

• Clinical objectives
• Evaluation methodology
• Literature search strategy
• Acceptance criteria
• Clinical data sources
• Equivalence considerations
• Risk-benefit assessment methodology

A robust CEP ensures consistency throughout the evaluation process.

Clinical Data Collection

Clinical evidence may come from several sources, including:

• Published scientific literature
• Clinical investigations
• Post-market surveillance
• Post-Market Clinical Follow-up (PMCF)
• Complaint records
• Vigilance reports
• Registry data
• Real-world clinical evidence

All data must be critically evaluated for relevance, quality, and reliability.

Literature Review

A systematic literature review is one of the most important aspects of CER writing.

The review includes:

• Database selection
• Search strategy
• Inclusion criteria
• Exclusion criteria
• Article screening
• Data extraction
• Critical appraisal

The objective is to identify high-quality clinical evidence supporting device safety and performance.

Clinical Data Appraisal

Collected evidence is critically analyzed to determine:

• Scientific validity
• Clinical relevance
• Data quality
• Statistical significance
• Potential bias
• Limitations

Only reliable evidence should be used to support regulatory conclusions.

Risk-Benefit Analysis

Manufacturers must demonstrate that the clinical benefits outweigh the identified risks.

The analysis considers:

• Device performance
• Clinical outcomes
• Adverse events
• Residual risks
• Risk controls
• Benefit justification

This assessment supports compliance with EU MDR General Safety and Performance Requirements.

Conclusions

The CER concludes whether:

• Clinical evidence is sufficient
• The device performs as intended
• Risks remain acceptable
• Benefit-risk profile is favorable
• Additional clinical data are required
• Post-market activities remain appropriate

The conclusions should be supported by objective evidence throughout the report.

CER Writing Under EU MDR

Compared with previous regulatory requirements, EU MDR significantly strengthens clinical evaluation expectations.

Manufacturers must now provide:

• More comprehensive clinical evidence
• Continuous clinical evaluation
• Regular CER updates
• Stronger post-market surveillance
• PMCF integration
• Improved risk management
• Enhanced literature reviews
• Greater transparency

Clinical evaluation is now considered a continuous lifecycle activity rather than a one-time submission.

Common Challenges in CER Writing

Medical device manufacturers frequently encounter challenges such as:

• Limited clinical data
• Complex literature searches
• Equivalence justification
• Inconsistent documentation
• Regulatory updates
• Notified body expectations
• Clinical data gaps
• Resource limitations

Experienced regulatory consultants help address these challenges while ensuring compliance with current regulatory requirements.

Best Practices for CER Writing

Effective CER preparation includes:

• Following MDR requirements
• Conducting systematic literature reviews
• Using qualified clinical evaluators
• Maintaining traceable documentation
• Integrating risk management
• Updating reports regularly
• Monitoring post-market data
• Supporting conclusions with evidence

These practices improve submission quality and reduce regulatory review times.

Benefits of Professional CER Writing Services

Outsourcing CER writing offers numerous advantages.

Professional consultants provide:

• Experienced clinical evaluators
• Regulatory expertise
• Scientific writing
• Literature review management
• MDR compliance
• Gap analysis
• PMCF integration
• Technical documentation support

Specialist support helps manufacturers prepare accurate, defensible, and compliant Clinical Evaluation Reports.

Future Trends in Clinical Evaluation

Clinical evaluation continues to evolve alongside medical technology.

Emerging trends include:

• Artificial intelligence for literature screening
• Increased use of real-world evidence
• Digital clinical databases
• Enhanced PMCF programs
• Greater regulatory harmonization
• Improved data analytics
• Continuous clinical evaluation
• Electronic technical documentation

Manufacturers that adopt these approaches will strengthen regulatory compliance while improving efficiency.

Conclusion

CER writing medical device is a fundamental requirement for demonstrating the clinical safety and performance of medical devices under the EU MDR. A well-prepared Clinical Evaluation Report supports CE marking, satisfies notified body expectations, and provides evidence that a device delivers its intended clinical benefits while maintaining an acceptable benefit-risk profile.

By combining scientific expertise, regulatory knowledge, and systematic clinical evaluation, manufacturers can confidently navigate the complex regulatory landscape and maintain compliance throughout the entire product lifecycle.

Frequently Asked Questions (FAQs)

1. What is a Clinical Evaluation Report (CER)?

A Clinical Evaluation Report is a scientific document that evaluates the clinical safety, performance, and benefit-risk profile of a medical device using available clinical evidence.

2. Is a CER mandatory under EU MDR?

Yes. Most medical devices marketed under the EU Medical Device Regulation (EU MDR 2017/745) require a Clinical Evaluation Report as part of the technical documentation.

3. What information is included in a CER?

A CER typically includes the device description, Clinical Evaluation Plan, literature review, clinical data appraisal, risk-benefit analysis, post-market surveillance information, and overall conclusions.

4. How often should a CER be updated?

CERs should be updated regularly based on the device risk classification, post-market surveillance findings, new clinical evidence, and regulatory requirements.

5. Who can prepare a Clinical Evaluation Report?

A CER should be prepared or reviewed by qualified professionals with expertise in clinical evaluation, regulatory affairs, medical writing, and the relevant medical specialty.

6. How can regulatory consultants help with CER writing?

Regulatory consultants support literature reviews, clinical evaluations, risk assessments, PMCF integration, MDR compliance, technical documentation, and preparation of high-quality CERs that meet notified body expectations.

About Acorn Regulatory

Acorn Regulatory is a trusted regulatory consultancy specializing in CER writing medical device services for manufacturers across Ireland and international markets. Our experienced team provides end-to-end support for Clinical Evaluation Reports (CERs), EU MDR compliance, clinical evaluations, literature reviews, Post-Market Clinical Follow-up (PMCF), risk management, technical documentation, and regulatory strategy. We work closely with medical device manufacturers to develop scientifically robust, MDR-compliant CERs that support CE marking, streamline regulatory submissions, and maintain compliance throughout the product lifecycle.